| |
[摘要]：In this issue of Cell Stem Cell, Heidel et al. (2012) use genetic and pharmacological approaches to reveal that Wnt/beta-catenin signaling is required for leukemic stem cell (LSC) maintenance in chronic myeloid leukemia. They demonstrate that beta-catenin inactivation targets imanitib-resistant LSCs in vivo. |
|
